Clinical Trials Logo

Colonic Disease clinical trials

View clinical trials related to Colonic Disease.

Filter by:

NCT ID: NCT06435377 Not yet recruiting - Colonic Disease Clinical Trials

Efficacy, Safety and Recurrence After Cold-EMR Plus APC for Large Colonic Lesions

EMR+APC
Start date: July 1, 2024
Phase:
Study type: Observational

This prospective observational study aims to evaluate the efficacy, safety and recurrence of cold-snaring for large colonic lesions combined with argon plasma coagulation of the resection bed.

NCT ID: NCT06271538 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

Start date: May 31, 2024
Phase: Phase 4
Study type: Interventional

The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention.

NCT ID: NCT06031051 Recruiting - Colonic Disease Clinical Trials

Capsule Endoscopy as an Alternative to Colonoscopy

CAPSUCOVID
Start date: December 22, 2021
Phase: N/A
Study type: Interventional

This is a prospective, multicenter, interventional study assessing CE, in patients already scheduled for colonoscopy at tertiary referral hospitals, as a technique to reduce the number of unnecessary colonoscopies and identify patients to prioritize in endoscopy waiting lists.

NCT ID: NCT05836064 Not yet recruiting - Colonic Neoplasms Clinical Trials

GastroBot: Artificial Intelligence Applied to Bowel Preparation

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

It is estimated that about 20% of colonoscopies have inadequate preparation. (5) This is associated with lengthy procedures and less detection of adenomas, reduces the screening intervals, and increases the costs and risks of complications. Several strategies have been proposed to improve the quality of bowel preparation. Mobile healthcare Apps have been developed to increase adherence to bowel preparation agents, improving the quality of bowel preparation. However, adherence to mobile healthcare Apps is also a quality criterion and a pending problem to solve with this new technology. GastroBot is a new technology based on artificial intelligence that allows, through a software bot, to carry out a personalized follow-up of the patient's bowel cleansing, advising the patient to overcome contingencies that arise with the preparation, which in other circumstances could lead to the failure of it. The primary aim of this study is to determine the improvement in bowel preparation after GastroBot assistance compared with the traditional explanation. As a secondary aim, this study also pursues to determine adenoma and polyp detection rates (ADR and PDR, respectively), bowel preparation agents' tolerance, and GastroBot functionality.

NCT ID: NCT05709145 Recruiting - Adherence, Patient Clinical Trials

Written Recommendation to Improve Adherence in Poor Bowel Preparation

Start date: May 11, 2023
Phase: N/A
Study type: Interventional

Our study aims to improve adherence to international clinical guidelines of repeating colonoscopy within 1 year, when bowel cleansing has failed. To this end, we have designed an ambispective study in patients with inadequately prepared colonoscopy. An intervention group to which a precise written recommendation on the need to repeat the colonoscopy in less than 1 year is attached, compared with a control group to which no written recommendations are provided. The sample size calculation is 171 patients per arm. In addition, we will quantify the percentage of pre-malignant and malignant lesions detected at repeat colonoscopy. We will also analyze factors that may be related to the recommendation or non-recommendation of repeat colonoscopy, as well as the association of variables related to adherence to repeat colonoscopy at an interval of less than 1 year. Through our study, we intend to demonstrate that a written recommendation, easily applicable and generalizable, has a positive impact on adherence to clinical follow-up guidelines in patients in whom bowel cleansing has failed.

NCT ID: NCT05540418 Completed - Colonic Disease Clinical Trials

Effect of Lavender Oil Inhalation in Colonoscopy Patients

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

Aim: In this study, it was aimed to determine the effect of lavender oil inhalation on the anxiety and comfort levels of patients who will undergo colonoscopy. Material and Method: In this randomized controlled, prospective study, 73 experimental and 72 control group patients who will experience colonoscopy in a training and research hospital in western Turkey were included. While lavender inhalation was applied to the patients in the experimental group, routine care was applied to the patients in the control group. The short-form state-trait anxiety scale and general comfort scale were used to collect data before and after the procedure. p<0.05 level was considered statistically significant.

NCT ID: NCT05512026 Not yet recruiting - Colonic Disease Clinical Trials

Performance of the Poseidon System for Fluid Management During Water-aided Colonoscopy

Start date: September 12, 2022
Phase: N/A
Study type: Interventional

To validate the performance of the Poseidon Systemâ„¢ for fluid management during water-aided endoscopic procedures in the colon.

NCT ID: NCT05391529 Not yet recruiting - Colonic Disease Clinical Trials

Patients Decision Making in Choosing Between Colonic Investigation Alternatives

Start date: May 2022
Phase:
Study type: Observational

This is a qualitative interview study to understand patients' priorities for different aspects of tests when considering a colonic investigation. Patients currently waiting for colon capsule endoscopy (CCE), and colonoscopy will be invited to take part. Semi-structured interviews will be carried out over the telephone following an interview guide. Recorded interviews will be transcribed and undergo thematic analysis. We will seek to publish the results of this study to inform future research and developments for colonic investigations.

NCT ID: NCT05322486 Recruiting - Neoplasms Clinical Trials

Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases

Start date: October 29, 2020
Phase:
Study type: Observational

Currently, the question remains whether palliative primary tumor resection could improve overall survival of minimally symptomatic patients with colorectal cancer and synchronous unresectable metastases. The aim of this study is to determine if there is an improvement in overall survival of palliative primary tumor resection followed by chemotherapy in minimally symptomatic patients with colorectal cancer and synchronous unresectable metastases compared to those of upfront chemotherapy/radiotherapy alone.

NCT ID: NCT05249335 Not yet recruiting - Intestinal Disease Clinical Trials

Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly

Start date: February 2022
Phase: Phase 4
Study type: Interventional

This study compares the effectiveness and stability of intestinal tablet (OST), an oral sulfate table (OST), developed in the form of pills, with 2L-PEG/Asc for examinees aged 70 or older who are scheduled for colonoscopy.